Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding CVS Health Corporation is 'Strong Hold'. Macroaxis provides CVS Health buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CVS positions. The advice algorithm takes into account all of CVS Health available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from CVS buy-and-hold prospective. Check also CVS Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.
For the selected time horizon CVS Health Corporation has a risk adjusted performance of 0.01, jensen alpha of 0.0, total risk alpha of 0.0 and treynor ratio of 0.0Macroaxis buy, hold, or sell suggestion module provides unbiased buy, hold, or sell recommendation that can be used to complement current average analyst sentiment on CVS Health Corporation. Our buy, hold, or sell suggestion engine suggest current market data to analyse the corporation potential to grow from the prospective of investors risk tolerance and investing horizon. To make sure CVS Health is not overpriced, please confirm all CVS Health fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash per Share and Beta . Given that CVS Health has Price to Earning of 20.50X, we suggest you validate CVS Health Corporation market performance and probability of bankruptcy to make sure the company can sustain itself next year given your prevailing risk tolerance and investing horizon.
CVS Health Trading Alerts and Improvement Suggestions
CVS Health has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
The company has 95.55B in debt with debt to equity (D/E) ratio of 159.2 . This implies that the company may be unable to create cash to meet all of its financial commitments. CVS Health has Current Ratio of 0.92 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.
The entity reported last year revenue of 209.62B. Reported Net Loss for the year was (174M) with profit before taxes, overhead, and interest of 30.88B.
Over 84.0% of CVS Health shares are held by institutions such as insurance companies
CVS Health Corporation has relatively low volatility with skewness of 1.03 and kurtosis of 3.55. However, we advise all investors to independently investigate CVS Health Corporation to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.